Clayton Partners’s Soleno Therapeutics SLNO Stock Holding History

Clayton Partners’s Portfolio SLNO Stock Details SLNO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$207K	Buy
2023 Q2	–	Sell
2023 Q1	$199K	Hold
2022 Q4	$184K	Sell
2022 Q3	$167K	Buy
2021 Q2	–	Sell
2021 Q1	$126K	Buy